(Q43117366)

English

Assessment of the relationship between age and the effect of risedronate treatment in women with postmenopausal osteoporosis: a pooled analysis of four studies

scientific article published on 22 March 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

0 references

Assessment of the relationship between age and the effect of risedronate treatment in women with postmenopausal osteoporosis: a pooled analysis of four studies (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

0 references

postmenopausal osteoporosis

1 reference

based on heuristic

inferred from title

author name string

Steven Boonen

1

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Andrea B Klemes

2

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Xiaojie Zhou

3

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Robert Lindsay

4

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

language of work or name

0 references

publication date

22 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Journal of the American Geriatrics Society

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

58

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

658-663

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

An estimate of the worldwide prevalence and disability associated with osteoporotic fractures

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2010.02763.X

21 January 2018

World-wide projections for hip fracture

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2010.02763.X

21 January 2018

Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2010.02763.X

21 January 2018

Secular trends in hip fracture incidence and recurrence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2010.02763.X

21 January 2018

Incidence of hip fractures in Korea

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2010.02763.X

21 January 2018

Recent trends in the incidence and lifetime risk of hip fracture in Tottori, Japan.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2010.02763.X

21 January 2018

Rising incidence of hip fracture in Gwangju City and Chonnam Province, Korea

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2010.02763.X

21 January 2018

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2010.02763.X

21 January 2018

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2010.02763.X

21 January 2018

The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2010.02763.X

21 January 2018

Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2010.02763.X

21 January 2018

Efficacy of risedronate on clinical vertebral fractures within six months.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2010.02763.X

21 January 2018

Changes in the prevalence of chronic disability in the United States black and nonblack population above age 65 from 1982 to 1999

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2010.02763.X

21 January 2018

Impact of recent fracture on health-related quality of life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2010.02763.X

21 January 2018

Quality of life in patients with osteoporosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2010.02763.X

21 January 2018

Health-related quality of life after osteoporotic fractures.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2010.02763.X

21 January 2018

The impact of incident vertebral and non-vertebral fractures on health related quality of life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2010.02763.X

21 January 2018

Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2010.02763.X

21 January 2018

The crippling consequences of fractures and their impact on quality of life

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2010.02763.X

21 January 2018

Estimating hip fracture morbidity, mortality and costs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2010.02763.X

21 January 2018

The Relationship Between Bone Density and Incident Vertebral Fracture in Men and Women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2010.02763.X

21 January 2018

The association between osteoporotic fractures and health-related quality of life as measured by the Health Utilities Index in the Canadian Multicentre Osteoporosis Study (CaMos)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2010.02763.X

21 January 2018

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2010.02763.X

21 January 2018

Identifiers

10.1111/J.1532-5415.2010.02763.X

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43117366&oldid=1981216157"